Vitamin D: Current Guidelines and Future Outlook

Anticancer Res. 2018 Feb;38(2):1145-1151. doi: 10.21873/anticanres.12333.

Abstract

Vitamin D is of public health interest because its deficiency is common and is associated with musculoskeletal diseases, as well as extraskeletal diseases, such as cancer, cardiovascular diseases, and infections. Several health authorities have reviewed the existing literature and published nutritional vitamin D guidelines for the general population. There was a wide consensus that serum 25-hydroxyvitamin D [25(OH)D] concentration should be used to assess vitamin D status and intake, and that musculoskeletal, and not extraskeletal, effects of vitamin D should be the basis for nutritional vitamin D guidelines. Recommended target levels for 25(OH)D range from 25 to 50 nmol/l (10 to 20 ng/ml), corresponding to a vitamin D intake of 400 to 800 International Units (10 to 20 μg) per day. It is of concern that significant sections of the general population do not meet these recommended vitamin D levels. This definitely requires action from a public health perspective.

Keywords: 25(OH)D; Vitamin D; epidemiology; guidelines; review; supplementation.

Publication types

  • Review

MeSH terms

  • Dietary Supplements*
  • Humans
  • Practice Guidelines as Topic / standards*
  • Vitamin D / administration & dosage*
  • Vitamin D / blood
  • Vitamin D Deficiency / blood
  • Vitamin D Deficiency / prevention & control*
  • Vitamins / administration & dosage*
  • Vitamins / blood

Substances

  • Vitamins
  • Vitamin D